The RGS protein inhibitor CCG-4986 is a covalent modifier of the RGS4 Gα-interaction face
- 30 September 2007
- journal article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1774 (9), 1213-1220
- https://doi.org/10.1016/j.bbapap.2007.06.002
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- How many drug targets are there?Nature Reviews Drug Discovery, 2006
- G-protein signaling: back to the futureCellular and Molecular Life Sciences, 2005
- REGULATORs OF G PROTEIN SIGNALING & DRUGS OF ABUSEMolecular Interventions, 2005
- The GAPs, GEFs, and GDIs of heterotrimeric G-protein alpha subunitsInternational Journal of Biological Sciences, 2005
- The G DIMER as a NOVEL SOURCE of SELECTIVITY in G-Protein Signaling: GGL-ing AT CONVENTIONMolecular Interventions, 2004
- RGS Proteins: G Protein-Coupled Receptors Meet Their MatchASSAY and Drug Development Technologies, 2003
- Regulators of G-Protein signalling as new central nervous system drug targetsNature Reviews Drug Discovery, 2002
- GTPase-Activating Proteins for Heterotrimeric G Proteins: Regulators of G Protein Signaling (RGS) and RGS-Like ProteinsAnnual Review of Biochemistry, 2000
- GAIP and RGS4 Are GTPase-Activating Proteins for the Gi Subfamily of G Protein α SubunitsCell, 1996
- A new family of regulators of G-protein-coupled receptors?Current Biology, 1996